Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease
A 2024 study from the International Foundation of Employee Benefit Plans showed that employer coverage of GLP-1s is still limited, with 34% of corporate plans currently providing coverage for non-diabetic patients who want to lose weight (up 8 percentage points from 2023)
Peptides such as BPC-157, sermorelin, and CJC-1295 are also peptides but do nothing similar
It is composed of 83 amino acids, with an additional 13 amino acids at the N-terminal end compared to regular IGF-1
It's in a class of medications called glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptor agonists
The World Health Organization recently teased a massive U-turn on its recommendation of semaglutides, and while there's no denying these injections can have some impressive results, we're warned about side effects ranging from 'Ozempic breath' to a potential mental health crisis